163 related articles for article (PubMed ID: 37627085)
1. CPSF3 Promotes Pre-mRNA Splicing and Prevents CircRNA Cyclization in Hepatocellular Carcinoma.
Huang Y; Ji H; Dong J; Wang X; He Z; Cheng Z; Zhu Q
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627085
[TBL] [Abstract][Full Text] [Related]
2. NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.
Li X; Ding J; Wang X; Cheng Z; Zhu Q
Oncogene; 2020 Jan; 39(4):891-904. PubMed ID: 31570791
[TBL] [Abstract][Full Text] [Related]
3. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
4. JTE-607, a multiple cytokine production inhibitor, targets CPSF3 and inhibits pre-mRNA processing.
Kakegawa J; Sakane N; Suzuki K; Yoshida T
Biochem Biophys Res Commun; 2019 Oct; 518(1):32-37. PubMed ID: 31399191
[TBL] [Abstract][Full Text] [Related]
5. Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma.
Li N; Jiang S; Fu R; Lv J; Yao J; Mai J; Hua X; Chen H; Liu J; Lu M
Biomark Med; 2021 Apr; 15(5):347-358. PubMed ID: 33666519
[No Abstract] [Full Text] [Related]
6. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
[TBL] [Abstract][Full Text] [Related]
7. CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing.
Alahmari AA; Chaubey AH; Jonnakuti VS; Tisdale AA; Schwarz CD; Cornwell AC; Maraszek KE; Paterson EJ; Kim M; Venkat S; Gomez EC; Wang J; Gurova KV; Yalamanchili HK; Feigin ME
RNA; 2024 Feb; 30(3):281-297. PubMed ID: 38191171
[TBL] [Abstract][Full Text] [Related]
8. High-throughput circular RNA sequencing reveals the profiles of circular RNA in non-cirrhotic hepatocellular carcinoma.
Li H; Xu L; Yi P; Li L; Yan T; Xie L; Zhu Z
BMC Cancer; 2022 Aug; 22(1):857. PubMed ID: 35931993
[TBL] [Abstract][Full Text] [Related]
9. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
[TBL] [Abstract][Full Text] [Related]
10. CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
Wang X; Dong J; Li X; Cheng Z; Zhu Q
Oncogene; 2021 Jun; 40(25):4338-4351. PubMed ID: 34103682
[TBL] [Abstract][Full Text] [Related]
11. Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma.
Mo M; Liu B; Luo Y; Tan JHJ; Zeng X; Zeng X; Huang D; Li C; Liu S; Qiu X
Front Mol Biosci; 2022; 9():801478. PubMed ID: 35141281
[No Abstract] [Full Text] [Related]
12. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma.
Han J; Thurnherr T; Chung AYF; Goh BKP; Chow PKH; Chan CY; Cheow PC; Lee SY; Lim TKH; Chong SS; Ooi LLPJ; Lee CG
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199580
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma.
Luo Z; Mao X; Cui W
Med Oncol; 2019 Sep; 36(10):86. PubMed ID: 31494761
[TBL] [Abstract][Full Text] [Related]
15. Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
Deng R; Cui X; Dong Y; Tang Y; Tao X; Wang S; Wang J; Chen L
Front Genet; 2021; 12():626764. PubMed ID: 33719338
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing analysis reveals the competing endogenous RNAs interplay in resected hepatocellular carcinoma patients who received interferon-alpha therapy.
Wu Y; Wang L; Wang X; Zhao Y; Mao A; Zhang N; Zhou J; Pan Q; Zhu W; Wang L
Cancer Cell Int; 2021 Sep; 21(1):464. PubMed ID: 34488748
[TBL] [Abstract][Full Text] [Related]
18. CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer.
Ning Y; Liu W; Guan X; Xie X; Zhang Y
Oncol Lett; 2019 Sep; 18(3):2835-2844. PubMed ID: 31452762
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of RNA-seq in hepatocellular carcinoma reveals competing endogenous RNA network composed of circRNA, lncRNA, and mRNA.
Zhou F; Kang Q; Ma J; Cai J; Chen Y; Qu K; Li F
Medicine (Baltimore); 2023 Feb; 102(8):e32915. PubMed ID: 36827016
[TBL] [Abstract][Full Text] [Related]
20. Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target.
Yao R; Zou H; Liao W
Front Oncol; 2018; 8():332. PubMed ID: 30191143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
